维普中文期刊产品整合服务
80篇 您的检索式:作者名="KERKELA R"
    题名 作者 年代 出处 被引量
1Cardiotoxicity of the cancer therapeutic agent imatinib mesylate显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
2Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib显示文摘CHU TF RUPNICK MA KERKELA R 2007Lancet2007,370,:1
3Cardiotoxicity of the cancer therapeutic agent imatinib mesylate显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
4Cardiotoxicity and the can- cer therapeutic agent imatinib metysilate 显示文摘Kerkela R Grazzete L Yacobi R 2006Nat Med2006,12,8:1
5Cardiotoxicity of the cancer therapeutic agent imatinib mesylate 显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
6Differential patterns of stromelysin- 2 (MMP-10) and MTI-MMP (MMP-14) expression in epithelial skin cancers 显示文摘Kerkela E Ala-aho R Lohi J 2001Br J Cancer2001,84,5:1
7Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP(MMP-14) expres- sion in epithelial skin cancers显示文摘Kerkela E Ala-aho R Lohi J 2001Br J Cancer2001,84,5:1
8Cardiotoxicity of the cancer therapeutic agent imatinib mesylate显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
9Deletion of GSK- 3 beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation 显示文摘Kerkela R Kockeritz L Macaulay K 2008J Clin Invest2008,118,11:1
10Human macrophage metalloela-stase(MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation显示文摘KerkelA E Bohling T Herva R 2001Bone2001,29,5:1
11Differential patterns of stromelysin - 2 ( MMP - 10) and MT1 - MMP( MMP - 14) expression in epithelial skin cancers 显示文摘Kerkela E Ala - aho R Jeskanen L 2001Br J Cancer2001,84,5:1
12Carcliotoxicity of the cancer therapeutic agent imatinib mesylate 显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
13Expression of hu- man macrophage metaUoelastase( MMP- 12)by tumor cells in skin cancer显示文摘Kerkela E Ala - aho R Jeskanen L 2000J Invest Dermatol2000,114,6:1
14Cardiotoxieity of the cancer therapeutic agent imatinib mesylate显示文摘Kerkela R Grazette L Yacobi R 2006Nat Med2006,12,8:1
15Cardiotoxicity of the cancer therapeutic agent imatinib mesylate显示文摘Kerkela R Grazette L Yaeobi R et'al 2006Nat Med2006,12,8:1
16Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib 显示文摘Chu TF Rupnick MA Kerkela R 2007Lancet2007,370,9604:1
17Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib 显示文摘Chu TF Rupnick MA Kerkela R 2007Lancet2007,370,9604:1
18Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers显示文摘Kerkela E Ala-aho R Lohi J 2001Br J Cancer2001,84,5:1
19Deletion of GSK-Sbeta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation 显示文摘Kerkela R Kockeritz L Macaulay K 2008J Clin Invest2008,118,11:1
20Differential patterns of stromelysin - 2 ( MMP - 10) and MT1 - MMP ( MMP - 14) expression in epithelial skin cancers显示文摘Kerkela E Ala - aho R Jeskanen L 2001Br J Cancer2001,84,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费